🇺🇸 FDA

Company profile · Sponsor

Medac

Medac Gesellschaft fuer klinische Spezialpraeparate mbH

E7BF8D0 · EMA pharma EU
Pipeline
3
Drugs
0
Patents
0

Quick answer

Medac (E7BF8D0) is a pharma company. headquartered in EU. listed on EMA. NovaPharmaNews links 3 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker E7BF8D0
Exchange EMA
Company type pharma
Headquarters EU

Pipeline (3)

Search pipeline →

  1. MC0518, EVEROLIMUS, MYCOPHENOLIC ACID , ANTITHYMOCYTE IMMUNOGLOBULIN (RABBIT)

    Medac

    Steroid refractory Acute Graft versus host Disease

    phase 3 small molecule active

    1 trial

  2. METHOTREXATE, METHOTREXATE, DESOXIMETASONE, TACROLIMUS, placebo, Acidum folicum Léčiva 10 mg obalené tablety, FOLIC ACID

    Medac

    moderate to severe atopic dermatitis

    phase 3 small molecule active

    1 trial

  3. Cardiac safety of treosulfan chemotherapy prior to stem cell transplantation in patients with leukemia.

    Medac

    Subjects with AML ( Acute myeloid leukaemia) or MDS (Myelodysplastic syndrome) undergoing allogeneic hematopoietic stem cell transplantation

    phase 1 other active

    1 trial

Frequently asked questions

What is Medac?

Medac (E7BF8D0) is a pharma company. headquartered in EU. listed on EMA. NovaPharmaNews links 3 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Medac sponsor?

We track 3 ClinicalTrials.gov-linked programs for Medac, including MC0518, EVEROLIMUS, MYCOPHENOLIC ACID , ANTITHYMOCYTE IMMUNOGLOBULIN (RABBIT) and 2 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Medac company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.